Form 4 for EW Edwards Lifesciences
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-10 · accession 0001225208-25-009841 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-10 | 2025-12-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $59.26 | +11.3K | 61.7K | +23% | +$672.0K |
| D | 2025-12-10 | 2025-12-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $83.83 | -11.3K | 50.4K | -18% | -$950.6K |
| D | 2025-12-10 | 2025-12-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | -11.3K | 45.4K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-10 | M | A | 11,340 | $59.26 | 61,696.37 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-10 | S | D | 11,340 | $83.83 | 50,356.37 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $83.465 to $84.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2025-12-10 | M | D | 11,340 | $0.00 | 45,360 | D | $59.26 · 2019-06-08 to 2026-05-07 | 11,340 Common Stock |